VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 39,992 Value ($000) $449 Avg Close — Range —
Q1 2025
Shares 40,173 Value ($000) $184 Avg Close — Range —
Q4 2024
Shares 40,173 Value ($000) $227 Avg Close — Range —
Q3 2024
Shares 40,173 Value ($000) $194 Avg Close — Range —
Q2 2024
Shares 40,173 Value ($000) $196 Avg Close — Range —
Q1 2024
Shares 34,263 Value ($000) $455 Avg Close — Range —
Q4 2023
Shares 27,058 Value ($000) $377 Avg Close — Range —
Q3 2023
Shares 27,058 Value ($000) $359 Avg Close — Range —
Q2 2023
Shares 27,058 Value ($000) $507 Avg Close — Range —
Q1 2023
Shares 24,677 Value ($000) $356 Avg Close — Range —
Q4 2022
Shares 24,677 Value ($000) $478 Avg Close — Range —
Q3 2022
Shares 24,677 Value ($000) $848 Avg Close — Range —
Q2 2022
Shares 20,938 Value ($000) $320 Avg Close — Range —
Q1 2022
Shares 20,938 Value ($000) $478 Avg Close — Range —
Q4 2021
Shares 5,814 Value ($000) $214 Avg Close — Range —
Q3 2021
Shares 5,814 Value ($000) $273 Avg Close — Range —